FDA approves controversial drug for use in Alzheimer’s disease

0
(Natural News) The Food and Drug Administration (FDA) recently approved a drug for Alzheimer’s disease despite warnings from experts that the controversial treatment hasn’t been shown to slow the disease. American biotechnology company Biogen developed the drug with Japanese pharmaceutical company Esai. The drug, known as aducanumab, is the first Alzheimer’s treatment approved by the FDA in almost 20…
Loading...